MAJOR CARDIOVASCULAR EVENT
Clinical trials for MAJOR CARDIOVASCULAR EVENT explained in plain language.
Never miss a new study
Get alerted when new MAJOR CARDIOVASCULAR EVENT trials appear
Sign up with your email to follow new studies for MAJOR CARDIOVASCULAR EVENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart drug repatha® tested in 7,000 chinese patients to cut deadly events
Disease control Recruiting nowThis study looks at whether adding Repatha® to usual care lowers the risk of major heart problems like heart attacks, strokes, and heart-related death in Chinese adults with established heart disease. About 7,000 participants will be followed to compare those getting Repatha® plu…
Matched conditions: MAJOR CARDIOVASCULAR EVENT
Sponsor: Amgen • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
Heart health app aims to cut cholesterol and save lives in 7-Year trial
Disease control Recruiting nowThis study tests whether a digital heart health program (app and online sessions) added to standard care can lower cholesterol and reduce heart attacks better than standard care alone. About 1,100 adults with heart disease or high cholesterol who are already on statins will be fo…
Matched conditions: MAJOR CARDIOVASCULAR EVENT
Phase: NA • Sponsor: University of Toronto • Aim: Disease control
Last updated May 11, 2026 20:40 UTC